ARTICLE | Distillery Therapeutics
Therapeutics: Sudan ebolavirus RNA-dependent RNA polymerase cofactor VP35 (SUDV VP35)
September 15, 2016 7:00 AM UTC
Non-human primate studies suggest siRNA targeting SUDV VP35 could help treat Sudan ebolavirus infection. In rhesus macaques challenged with lethal doses of Sudan ebolavirus, lipid nanoparticle-encapsu...